UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-14956 Bausch Health Companies Inc. (Exact name of registrant as specified in its charter) British Columbia , Canada 98-0448205 (State ...

Exhibit 99.1 1 SCH Health | --- | --- | |----------------------------|-------| | | | | Investor Contact: | | | Garen Sarafian | | | ir@bauschhealth.com | | | (877) 281-6642 (toll free) | | | --- | --- | |-------------------------------------------|-------| | | | | Media Contact: | | | Katie Savastano | | | corporate.communications@bauschhealth.com | | | (908) 541-3785 | | BAUSCH HEALTH ANNOUNCES THIRD QUARTER 2024 RESULTS • Sixth consecutive quarter of year-over-year growth in both Revenue and Adjusted EBIT ...

Bausch Health Companies Today BHC Bausch Health Companies $8.05 -0.03 (-0.37%) 52-Week Range $3.96 ▼ $11.46 Price Target $7.33 Add to Watchlist Bausch Health NYSE: BHC stock has been on a wild ride recently, with a dramatic surge in value over the last month. The catalyst for this surge is a wave of rumors suggesting that Bausch + Lomb NYSE: BLCO, Bausch Health's spinoff eye care business, is considering a buyout. This potential sale has sparked significant interest among investors, as it could lead to a mu ...

Shares of Bausch Health, Inc. (BHC) gained 14.7% in a week on reports of refinancing its debt to enable the impending sale of its eye care company, Bausch + Lomb (BLCO) . The industry declined 0.6% during this timeframe. The sale, intended to separate both companies, is stuck for quite some time now. Hence, reports of BHC moving forward have encouraged investors. Image Source: Zacks Investment Research BHC's Plans to Separate BLCO In August 2020, BHC announced its plan to separate its eye health business, c ...

Tom Yeung here with your Sunday Digest. During the early 1990s real estate crisis, the Marriott Corp. hotel chain found itself in trouble. The company had overexpanded during the boom times of the 1980s, and the ensuing crash had left it with over a hundred unsellable hotels in an overbuilt market. To save the firm, Chief Financial Officer Stephen Bollenbach created a breakup plan for the hotel chain. Under the agreement, Marriott would keep its lucrative management business (the "good" Marriott), while spi ...

Gain access to all of the market research and financial analytics used in the preparation of this article plus exclusive content and pharma, healthcare and biotech investment recommendations and research / analytics by subscribing to my channel, Haggerston BioHealth. The group is for both novice and experienced biotech investors. It provides catalysts to look out for and buy and sell ratings. It also provides product sales and forecasts for all the Big Pharmas, forecasting, integrated financial statements, ...

Bausch Health (BHC) shares rallied 11.7% in the last trading session to close at $8.02. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 23.2% gain over the past four weeks. Bausch stock witnessed a rally after a Bloomberg report said that the company is working with Jefferies Financial Group to explore refinancing some of its debt. The debt refinancing is expected to help the company in the impending spinoff ...

In January, I wrote an article in which I recommended Bausch + Lomb (NYSE: BLCO ) on the grounds that it was trading near its 52-week lows and looked like a good rebound candidate. BLCO stock has I'm Jason Ditz and I have 20 years of experience in foreign policy research. My work has appeared in Forbes, Toronto Star, Minneapolis Star-Tribune, Providence Journal, Washington Times and the Detroit Free Press, as well as American Conservative Magazine and the Quincy Institute for Responsible Statecraft. I have ...

CHICAGO, ILLINOIS - MAY 05: Bausch + Lomb eye vitamins are offered for sale at a drug store on May 05, 2022 in Chicago, Illinois. Bausch + Lomb parent company Bausch Health is spinning off the eye-care company with an upcoming IPO which will list on the New York Stock Exchange and TSX with the ticker symbol "BLCO". (Photo by Scott Olson/Getty Images) In May 2022 , Bausch + Lomb (BLCO) was spun off as a separate publicly traded entity, but it continues to be a core part of Bausch Health's business through it ...

About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, The ...